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INTRODUCTION
Survivors of congenital diaphragmatic hernia (CDH) have increased with the introduction of new treatment modalities, including gentle ventilation with permissive hypercapnea, high frequency ventilation, inhaled nitric oxide, and extracorporeal membrane oxygenation (ECMO) [1] [2] [3] .
CDH survivors have been reported to experience ongoing medical morbidity [4] . Some institution reports of long-term sequelae include pulmonary and gastrointestinal problems, neurodevelopmental morbidity, orthopaedic disorders, and a less favourable quality of life [4] . Although some single-institution reports have addressed the issue of long-term outcome of CDH survivors, the variability in patient populations, management, and methods for and length of follow-up make if difficult to draw firm conclusions about the quality of life of these patients.
The aim of this review is to describe the long-term functional impact of CDH repair on the survivors of a single institution cohort of newborns over a 14-year period.
METHODS
The follow up medical charts of 39 CDH survivors treated at a tertiary neonatal intensive care unit (NICU), from January 1997 to December 2010, were analyzed. Data retrieved included actual age, weight, length/ height, head circumference, respiratory, cardiovascular, neurological, gastrointestinal and musculoskeletal outcomes. Whenever data seemed incomplete or any doubt arouse in the medical charts analysis the child`s current clinical problems, if any, were assessed on a telephone-based parent medical history, which addressed nutritional status, cardiopulmonary and gastrointestinal problems, as well as issues with vision, hearing, speech, behaviour, learning, muscle tone and orthopaedic problems.
After discharge from hospital, CDH survivors are cared for in a multidisciplinary follow up. Follow up schedule may change as indicated, but usually includes regular evaluations every three months during the first year of life, every six months during the second year of life, and once a year after two years of age. Anthropometrical indexes are evaluated in all visits and nutritional support by a dietician is indicated when weight is below the fifth percentile, or children have crossed down two major growth percentiles without any other evident aetiology, according to the charts of the National We considered failure to thrive those children below the fifth percentile for age and those that have crossed down two major growth percentiles without any other evident morbidity. Diagnosis of gastro-esophageal reflux was done using upper gastrointestinal contrast study. Patients with gastro-esophageal reflux disease were evaluated for esophagitis by endoscopic examination. We considered asthma in those patients presenting with more than three episodes of bronchospasm per year requiring bronchodilator treatment, when excluded other causes of bronchospasm such as allergic rhinitis, sinusitis, laringotracheobronchomalacia or stenosis, chronic exposure to environmental tobacco smoke, viral infections, gastro-esophageal reflux and cystic fibrosis [5] . Chronic lung disease was defined as oxygen requirement for at least six weeks for a transcutaneous saturation of 90% to 95%, along with the use of bronchodilators and inhaled steroids, or the need of respiratory support, and an abnormal chest radiograph. Neurodevelopment is assessed at the neurodevelopmental consultation using the Griffiths Mental Developmental Scale. Cerebral palsy is classified according to the Gross Motor Function Classification System [6] . Follow-up since 1997 ranged between 1 and 14 years. The median age at follow up was 70 (4 -162) months. Survivors were not without morbidity. The sequelae found in the follow up are listed in table 1. Seven patients (17.9%) present one sequelae, six patients (15.3%) present two sequelae, three patients (7.6%) present three sequelae, two patients (5.1%) present four sequelae, and three patient (7.5%) presents six, seven and eight sequelae, respectively. In the remaining 10 patients no sequelae were detected. No cases of sensorioneural hearing loss were diagnosed. One patient was deceased by three months old with respiratory failure associated to pneumonia and sepsis. Another patient was deceased by eight months of age, after hernia recurrence repair, need for fundoplication, gastrostomy feeding, chronic lung disease, persistent pulmonary hypertension and multiple respiratory infections.
RESULTS

From
The ongoing morbidity is more prevalent in those patients under five years of age, when compared to those over five, and this effect is more relevant on respiratory and gastrointestinal morbidity.
The different aspects of therapy used in our CDH survivors are summarized in table 2.
DISCUSSION
More attention is now focused on long-term follow up of CDH survivors. The different centres treating CDH survivors have different follow up schedules and methods of therapy. They also have different protocols for the acute phase treatment at the NICU, and some provide ECMO support. Thus, comparing results of CDH survivors follow up from different centres make it difficult to draw firm conclusions [7, 8] . With this idea in mind we decided to present our own follow up schedule and the different aspects of the used therapy, and allow the readers to compare with their own centre experience. Of course, the proposed follow up schedule and therapies may change for patients requiring strict follow up with closer evaluations, or patents with particular specificities. In addition to long-term pulmonary sequelae in some survivors, follow up studies of infants with CDH have revealed associated non-pulmonary morbidity, including neurocognitive delay, gastroesophageal reflux and other gastrointestinal abnormalities, hearing loss, hernia recurrence, poor growth, and musculoskeletal abnormalities.
Pulmonary outcome
Obstructive symptoms such as bronchospasm or wheezing are frequently reported in CDH survivors, and a high proportion had been diagnosed with asthma [9, 10 -12]. In our study, obstructive symptoms were the most common respiratory morbidities. These symptoms are perceived to decline with ageing, although abnormalities in pulmonary function tests persist. Most adolescent CDH survivors are healthy and enjoy normal lives. However, in a significant proportion of patients, long-term pulmonary sequelae are detectable and dependent on the severity of lung hypoplasia and the degree of lung injury [9, 10].
CDH survivors suffer from recurrent respiratory tract infections in infancy and early childhood [6, 12] . Recurrent pneumonia or a past history of pneumonia has been found in 26% to 39% of CDH survivors [6] .
Chronic lung disease (defined as the need for bronchodilators, diuretics, or oxygen supplementation) has been reported in CDH survivors, but its incidence is unclear [13] .
One study reported chronic lung disease in 41% of the survivors [14] . Our experience is limited to five patients. The higher prevalence of chronic lung disease has been reported in patients requiring ECMO or patch repair of the diaphragmatic defect. The severity of chronic lung disease may require prolonged respiratory support and tracheostomy.
Recurrent herniation usually presents before three years of age. In our study this occurred in four patients, by fourth and fifth month age.
Although most CDH survivors are clinically normal, many of them present subclinical abnormalities in their chest radiographs, lung scintigraphy, and/or pulmonary functions tests. A careful respiratory follow up into adulthood is warranted.
Neurological outcome
A variable, but significant proportion of CDH survivors have neurological sequelae. In our sample, neurological sequelae were detected in seven (17.9%) of the survivors.
Several factors are associated with neurodevelopmental outcome in CDH survivors [15] . The need for extracorporeal membrane oxygenation seems related to a poorer neurological outcome. Whether this reflects a more severe primary disease or is a consequence of a more aggressive treatment is unclear, and probably both are true. A prolonged neonatal hospitalization, presumably reflecting the severity of the primary disorder, has been associated with a poorer neurological outcome [16] . A low socioeconomic status is another factor to enter in consideration with [9] .
Neurodevelopmental outcome is likely to improve with ageing. It is not surprising that initial development may be delayed, but tend to improve with time and with resolution of other organ disorders.
CDH survivors are at high risk of developing sensorioneural hearing loss, due to both the severity of primary disease and the exposure to numerous risk factors, including ototoxic medications, and prolonged mechanical ventilation with high oxygen tensions.
Fortunately none of our CDH survival presents sensorioneural hearing loss.
Neuroimaging abnormalities are relatively frequent in CDH survivors, although their meaning is unclear [5] . In this study, one case of cerebral palsy with cortical atrophy was diagnosed.
Long-term neurological follow up is warranted to early detection of neurological deficits and to provide adequate support.
Gastrointestinal outcome
Gastroesophageal reflux is the most common gastrointestinal sequelae [17] A significant number of CDH survivors show evidence of failure to thrive [2, 17] . In our study, this was present in 15.3% (n=6) of the patients. Gastroesophageal reflux disease may be one of the etiologies, but many other factors are implicated in the pathogenesis of growth failure in CDH patients, such as chronic lung disease and oral aversion.
Placement of a gastrostomy tube may be required in some patients with growth failure despite aggressive nutritional support.
Other gastrointestinal surgical problems resulting in significant chronic morbidity include intestinal adhesions with obstruction, volvulus secondary to malrotation, intestinal perforation, and ischemia. None of these problems were detected in this study.
survivors.
Musculoskeletal outcome
CDH survivors may suffer from musculoskeletal abnormalities until their growth has stopped, since there is a close relationship between the development of the lung, diaphragm, and the thoracic cage [19] . Chest asymmetry and pectus deformity are the most commonly described, followed by vertebral deformities (scoliosis and kyphosis) [13] . Excessive tension on the diaphragmatic repair, the thoracotomy, or the smaller thoracic cavity with smaller lung in the affected side are suggested as possible causes [13] .
In conclusion, CDH survivors present ongoing morbidities during infancy and childhood. This morbidity is more prevalent in the first years of live, and there is some improvement with growth. CDH survivors are a group of patients that requires long term periodic follow up in a multidisciplinary setting to provide adequate support and improve their quality of life. Cerebral palsy Multidisciplinary approach including physical therapists, speech pathologists, social workers, educators, development psychologists; parents are taught how to work with their child in daily activities and exercises designed to prevent the development of contractures; adaptative equipments (walkers, poles, standing frames, motorized wheelchairs, special feeding devices) surgical soft tissues procedures, rhizotomy procedure, assessment and treatment of lower urinary tract dysfunction ; drugs to treat spasticity including oral dantrolene sodium, benzodiazepines, baclofen, levodopa, carbamazepine, trihexyphenidyl and injection of botulinium toxin, may be used in selected cases.
Strabismus
Ophthalmic specialized correction; the causative types must be distinguished and treated accordingly.
Pectus excavatum
Based on severity of the deformity and extent of physiologic compromise: careful observation; use of physical therapy to address musculoskeletal compromise, and corrective surgery when significant physiologic compromise Scoliosis Depends on the extent of the curve and the degree of skeletal maturation. Treatment options include reassurance, observation, bracing, and surgery (spinal fusion)
Recurrence of hernia and patch rejection Surgery, reconstruction by direct muscle closure if possible; in large defects the use of a reverse latissimus dorsi muscle flap NAEPP -National Asthma Education and Prevention Program
